진원생명과학 주식회사

{
  "address": "서울특별시 영등포구",
  "ceo_name": "고광연, 한우근",
  "certificate": [
    {
      "cert_number": "20190102107",
      "changes": "",
      "disclosure_date": "2019-03-15",
      "first_cert_date": "2019-03-15",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2019-03-15 ~ 2021-03-14"
    },
    {
      "cert_number": "20210513020040",
      "changes": "",
      "disclosure_date": "2021-05-13",
      "first_cert_date": "2019-03-15",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2021-03-15 ~ 2024-03-14"
    },
    {
      "cert_number": "20240710020023",
      "changes": "대표자",
      "disclosure_date": "2024-07-10",
      "first_cert_date": "2019-03-15",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2024-07-10 ~ 2027-07-09"
    }
  ],
  "company_name": "진원생명과학 주식회사",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 77751599000,
      "cost_of_sales": 42644570000,
      "current_assets": 106718984000,
      "current_liabilities": 28557077000,
      "gross_profit": 2961436000,
      "net_income": -20047882000,
      "net_income_bs": -20113280000,
      "non_current_assets": 116513964000,
      "non_current_liabilities": 4767891000,
      "non_operating_expenses": 11108073000,
      "non_operating_income": 22328253000,
      "operating_profit": -31268062000,
      "revenue": 45606006000,
      "sga_expenses": 34229498000,
      "total_assets": 223232948000,
      "total_equity": 189907980000,
      "total_liabilities": 33324968000
    },
    "2023": {
      "capital_stock": 78473817000,
      "cost_of_sales": 35618271000,
      "current_assets": 23221858000,
      "current_liabilities": 13532690000,
      "gross_profit": 2187422000,
      "net_income": -70250810000,
      "net_income_bs": -70340720000,
      "non_current_assets": 118865148000,
      "non_current_liabilities": 8304166000,
      "non_operating_expenses": 60834557000,
      "non_operating_income": 16506611000,
      "operating_profit": -25922864000,
      "revenue": 37805693000,
      "sga_expenses": 28110286000,
      "total_assets": 142087006000,
      "total_equity": 120250150000,
      "total_liabilities": 21836856000
    },
    "2024": {
      "capital_stock": 80039035000,
      "cost_of_sales": 30977650000,
      "current_assets": 21713099000,
      "current_liabilities": 25458591000,
      "gross_profit": 2063265000,
      "net_income": -6325861000,
      "net_income_bs": -6103183000,
      "non_current_assets": 129598965000,
      "non_current_liabilities": 6714047000,
      "non_operating_expenses": 29147691000,
      "non_operating_income": 38477891000,
      "operating_profit": -15656061000,
      "revenue": 33040915000,
      "sga_expenses": 17719326000,
      "total_assets": 151312064000,
      "total_equity": 119139426000,
      "total_liabilities": 32172638000
    }
  },
  "industry": "그 외 기타 분류 안된 화학제품 제조업",
  "investment": [],
  "main_products": "플라스미드(DNA백신)",
  "phone": "02-3458-****",
  "years": [
    2024,
    2023,
    2022
  ]
}